Systematic evidence analysis for the transition from relapsing to secondary progressive Multiple Sclerosis in adults

被引：0
|
作者：
Badgujar, L. [1 ]
Khurana, V. [1 ]
Malepati, A. [1 ]
Meier, D. Piani [2 ]
Adlard, N. [2 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[2] Novartis Pharma AG, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO1208
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [1] The transition from relapsing remitting to secondary progressive multiple sclerosis
    Hourihan, S.
    BRITISH JOURNAL OF OCCUPATIONAL THERAPY, 2013, 76 : 162 - 162
  • [2] Exploring predictors for the transition from Relapsing to Secondary Progressive Multiple Sclerosis
    Bischof, Antje
    Papinutto, Nico
    Bevan, Carolyn
    Kirkish, Gina
    Stern, William
    Zhu, Alyssa
    Gelfand, Jeffrey
    Goodin, Douglas
    Crabtree-Hartman, Elizabeth
    Graves, Jennifer
    Green, Ari
    Waubant, Emmanuelle
    Zamvil, Scott
    Cree, Bruce
    Hauser, Stephen
    Henry, Roland
    NEUROLOGY, 2017, 88
  • [3] Imaging Predictors for the Transition from Relapsing to Secondary Progressive Multiple Sclerosis
    Bischof, Antje
    Papinutto, Nico
    Keshavan, Anisha
    Bevan, Carolyn
    Kirkish, Gina
    Stern, William
    Zhu, Alyssa
    Crabtree-Hartmann, Elizabeth
    Gelfand, Jeffrey
    Goodin, Douglas
    Graves, Jennifer S.
    Green, Ari
    Schlaeger, Regina M.
    Waubant, Emmanuelle
    Zamvil, Scott
    Cree, Bruce A. C.
    Hauser, Stephen L.
    Henry, Roland G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 100 - 100
  • [4] Unraveling diagnostic uncertainty in transition phase from relapsing remitting to secondary progressive multiple sclerosis
    Antonio, Carotenuto
    Elisabetta, Signoriello
    Roberta, Lanzillo
    Ylenia, Vaia
    Marcello, Moccia
    Simona, Bonavita
    Giacomo, Lus
    Vincenzo, Brescia Morra
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [5] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Sorensen, P. S.
    Christensen, J. C.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 131 - 132
  • [6] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Christensen, J. Romme
    Bornsen, L.
    Borup, R.
    Sorensen, P. S.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (14) : 1841 - 1848
  • [7] Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
    Ge, YL
    Grossman, RI
    Udupa, JK
    Wei, LG
    Mannon, LJ
    Polansky, M
    Kolson, DL
    RADIOLOGY, 2000, 214 (03) : 665 - 670
  • [8] Cortical grey matter ratio differentiates relapsing remitting multiple sclerosis from secondary progressive multiple sclerosis
    Fleer, J.
    Vermeulen, S.
    Parizel, P.
    Cras, P.
    Willekens, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1017 - 1017
  • [9] Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
    Castillo-Trivino, Tamara
    Braithwaite, Dejana
    Bacchetti, Peter
    Waubant, Emmanuelle
    PLOS ONE, 2013, 8 (07):
  • [10] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients with Relapsing-Remitting Multiple Sclerosis
    Kappos, L.
    Meier, D. P.
    Tomic, T.
    Haring, D.
    Bakshi, R.
    Meinert, R.
    Giovannoni, G.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 447 - 447
12345